EXACTLY...they tried to issue too many shares at the same time and it didn't work so the scrapped they whole thing. US listing would be a huge positive, IMO.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%